The Age
·general
·1 hour ago
New research finds better antibiotics for treating deadly golden staph infection
New research reveals that flucloxacillin, traditionally used to treat golden staph, has a lower survival rate and higher risk of side effects. In a world-first trial, alternative antibiotics cefazolin and benzylpenicillin showed better outcomes, prompting a shift in treatment as golden staph causes over 1,000 Australian deaths annually. Caitlin Alsop, a survivor, emphasized timely and effective treatment is critical.
Summary by OZbrief · The Age
Newer
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI



